Skip to main content
Case Study

Prurigo Nodularis Case Study

February 2, 2021July 25th, 2024

Prurigo Nodularis Case Study

Study Overview:

  • Rare indication
  • Protocol amendment slowed enrollment early in the study
  • Older study population (60-70 years) that struggled with completing eDiaries
  • Request to increase number of patients during study conduct from 200 to 280

Learn more about our related services and resources:

TFS Rare Diseases & Orphan Drugs

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Rare Disease Expertise

What Are the Phases of Clinical Research?
What Are the Phases of Clinical Research?
What Are the Phases of Clinical Research?Article

What Are the Phases of Clinical Research?

Explore the purpose, process, and characteristics of the four phases of clinical research, crucial for validating drug safety and efficacy.
Pediatric Rare Disease Studies: Patient Centric Approaches
Xtalks Webinar for TFS
Pediatric Rare Disease Studies: Patient Centric ApproachesWebinars

Pediatric Rare Disease Studies: Patient Centric Approaches

Discover the importance of patient-centricity in pediatric rare disease studies. TFS experts Scott Schliebner and Alison Sampson share insights and strategies for improving clinical trials, including patient engagement and decentralized…
Prurigo Nodularis Case Study
Prurigo Nodularis Case StudyCase Study

Prurigo Nodularis Case Study

Patient Recruitment of an international Phase III study in Prurigo Nodularis successfuly enrolled 6 weeks ahead of schedule.